Carlos González-Fernández

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Lipopolysaccharide Induced

Neuropathic Pain

Spinal Cord Injury

Ultrasound Guided

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Pau González, Carlos González-Fernández, Alfredo Maqueda, Virginia Pérez, Sara Escalera-Anzola, Ángel Rodríguez de Lope, Francisco Javier Arias, Alessandra Girotti, Francisco Javier Rodríguez
Silk-Elastin-like Polymers for Acute Intraparenchymal Treatment of the Traumatically Injured Spinal Cord: A First Systematic Experimental Approach. Pharmaceutics 14 (12) (2022)
Carlos González-Fernández, Pau González, Francisco González-Pérez, Francisco Javier Rodríguez
Characterization of Ex Vivo and In Vitro Wnt Transcriptome Induced by Spinal Cord Injury in Rat Microglial Cells. Brain sciences 12 (6) (2022)
Pau González, Carlos González-Fernández, Alfredo Maqueda, Virginia Pérez, Sara Escalera-Anzola, Ángel Rodríguez de Lope, Francisco Javier Arias, Alessandra Girotti, Francisco Javier Rodríguez
Silk-Elastin-like Polymers for Acute Intraparenchymal Treatment of the Traumatically Injured Spinal Cord: A First Systematic Experimental Approach. Pharmaceutics 14 (12) (2022)
Pau González, Carlos González-Fernández, Alfredo Maqueda, Virginia Pérez, Sara Escalera-Anzola, Ángel Rodríguez de Lope, Francisco Javier Arias, Alessandra Girotti, Francisco Javier Rodríguez
Silk-Elastin-like Polymers for Acute Intraparenchymal Treatment of the Traumatically Injured Spinal Cord: A First Systematic Experimental Approach. Pharmaceutics 14 (12) (2022)
Pau González, Carlos González-Fernández, Alfredo Maqueda, Virginia Pérez, Sara Escalera-Anzola, Ángel Rodríguez de Lope, Francisco Javier Arias, Alessandra Girotti, Francisco Javier Rodríguez
Silk-Elastin-like Polymers for Acute Intraparenchymal Treatment of the Traumatically Injured Spinal Cord: A First Systematic Experimental Approach. Pharmaceutics 14 (12) (2022)